prasugrel - Compound Summary (CID 6918456)
Also known as: Effient, 150322-43-3, Efient, CS-747, Prasita, CS 747, LY-640315, LY 640315
Molecular Formula: C20H20FNO3S   Molecular Weight: 373.441103   InChIKey: DTGLZDAWLRGWQN-UHFFFAOYSA-N
Prasugrel is a novel platelet inhibitor developed by Daiichi Sankyo Co. currently marketed in the United States in cooperation with Eli Lilly and Company for acute coronary syndromes planned for percutaneous coronary intervention (PCI). It is approved for use in the U.S., India and Europe.   From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Use and Manufacturing
Pharmacology
Biomedical Effects and Toxicity
Safety and Handling
Exposure Standards and Regulations
Literature
Patents
Biomolecular Interactions and Pathways
Biological Test Results
Classification
Chemical and Physical Properties
_ _